OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease
Clara Caenepeel, Gwen Falony, Kathleen Machiels, et al.
Gastroenterology (2023) Vol. 166, Iss. 3, pp. 483-495
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Predictive biomarkers for anti-TNF alpha therapy in IBD patients
Manoj Kumar, Selvasankar Murugesan, N Ibrahim, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14

Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility
Clara Caenepeel, S Deleu, Jorge Francisco Vazquez Castellanos, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 12

Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases
Arnau Vich Vila, Jingwan Zhang, Moting Liu, et al.
Gut (2024) Vol. 73, Iss. 11, pp. 1909-1920
Closed Access | Times Cited: 10

Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
Yi Zhang, Chengjun Mo, Penghui Ai, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1

Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference
Loris Riccardo Lopetuso, S Deleu, Pierluigi Puca, et al.
Inflammatory Bowel Diseases (2025)
Closed Access | Times Cited: 1

Associations between gut microbiota and sarcopenia or its defining parameters in older adults: A systematic review
Laurence Lapauw, A.L.B. Rutten, Jolan Dupont, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 6, pp. 2190-2207
Open Access | Times Cited: 6

Deciphering Microbial Composition in Patients with Inflammatory Bowel Disease: Implications for Therapeutic Response to Biologic Agents
Orazio Palmieri, Fabrizio Bossa, Stefano Castellana, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1260-1260
Open Access | Times Cited: 5

Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence
Anna Lucia Cannarozzi, Anna Latiano, Luca Massimino, et al.
United European Gastroenterology Journal (2024)
Open Access | Times Cited: 5

Community Types of the Human Gut Virome are Associated with Endoscopic Outcome in Ulcerative Colitis
Daan Jansen, Gwen Falony, Sara Vieira‐Silva, et al.
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 9, pp. 1504-1513
Open Access | Times Cited: 11

Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease
Femke M. Prins, Iwan J. Hidding, Marjolein A. Y. Klaassen, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4

Comprehensive care of ulcerative colitis: new treatment strategies
Thanaboon Chaemsupaphan, Arteen Arzivian, Rupert W. Leong
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access

Individual-network based predictions of microbial interaction signatures for response to biological therapies in IBD patients
Federico Melograna, Padhmanand Sudhakar, Behnam Yousefi, et al.
Frontiers in Molecular Biosciences (2025) Vol. 11
Open Access

The Role of Calprotectin in the Diagnosis and Treatment of Inflammatory Bowel Disease
Wenqian Wang, Wenfu Cao, Shenyun Zhang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1996-1996
Open Access

Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights
Daphne Moutsoglou, Pavithra Ramakrishnan, Byron P. Vaughn
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access

Role of Gut Microbiota and Metabolomics in Predicting Response to Vedolizumab in Inflammatory Bowel Disease: A Systematic Review
Vaidota Malinauskiene, Elena Cijauskaite, Goda Sadauskaite, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 476-476
Open Access

Recent developments in managing luminal microbial ecology in patients with inflammatory bowel disease: from evidence to microbiome-based diagnostic and personalized therapy
Erica Bonazzi, Caterina De Barba, G. Lorenzon, et al.
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access

Gut microbiota modulate intestinal inflammation by endoplasmic reticulum stress-autophagy-cell death signaling axis
Fei He, Yi Zheng, Mabrouk Elsabagh, et al.
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology (2025) Vol. 16, Iss. 1
Open Access

Incorporating Real‐World Variability in Clinical IBD Research
Anje A. te Velde
Journal of Evaluation in Clinical Practice (2025) Vol. 31, Iss. 4
Open Access

Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease
Femke M. Prins, Iwan J. Hidding, Marjolein A. Y. Klaassen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Dysbiosis in inflammatory bowel diseases: egg, not chicken
Eduard F. Stange
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2

Differential contributions of the gut microbiota and metabolome to pathomechanisms in ulcerative colitis: an in vitro analysis
Jonas Poppe, Leen Boesmans, Sara Vieira‐Silva, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top